Charles River Laboratories Intl (CRL)
110.00 x 19 144.50 x 2
Pre-market by (Cboe BZX)
114.66 -1.10 (-0.95%) 04/25/25 [NYSE]
110.00 x 19 144.50 x 2
Pre-market 113.50 -1.16 (-1.01%) 08:37 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CRL | HQY | BLCO | ||
| Company | Charles River Laboratories Intl | Healthequity | Bausch & Lomb Corp | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | ||
| Open | 113.33 | 86.00 | 13.98 | ||
| High | 113.33 | 86.00 | 13.98 | ||
| Low | 113.33 | 86.00 | 13.98 | ||
| Last | 113.33 | 86.00 | 13.98 | ||
| Change | -1.33 | +0.13 | +0.25 | ||
| % Change | -1.16% | +0.15% | +1.82% | ||
| Volume | 924 | 769 | 974 | ||
| 20-Day Average Volume | 2,515,526 | 1,050,043 | 799,239 | ||
| Previous Close | 114.66 | 85.87 | 13.73 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 120.26 | 83.46 | 12.66 | ||
| 20-Day Raw Stochastic | 34.65% | 80.23% | 83.02% | ||
| 20-Day Relative Strength | 37.97% | 46.56% | 50.75% | ||
| Weighted Alpha | -50.92 | +3.06 | -15.02 | ||
| Today's Opinion | 100% Sell | 56% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 80% Sell | 24% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.38% since 04/21/25 | +7.23% since 04/21/25 | +16.02% since 04/21/25 | ||
| Low | 101.00 on 04/22/25 | 81.23 on 04/22/25 | 12.08 on 04/22/25 | ||
| High | 116.06 on 04/23/25 | 88.53 on 04/23/25 | 13.98 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -27.14% since 03/28/25 | -1.10% since 03/28/25 | -1.06% since 03/28/25 | ||
| Low | 91.86 on 04/11/25 | 74.07 on 04/07/25 | 10.46 on 04/09/25 | ||
| High | 153.82 on 03/31/25 | 88.94 on 04/02/25 | 14.70 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | -30.74% since 01/28/25 | -20.16% since 01/28/25 | -19.70% since 01/28/25 | ||
| Low | 91.86 on 04/11/25 | 74.07 on 04/07/25 | 10.46 on 04/09/25 | ||
| High | 181.44 on 03/10/25 | 115.59 on 02/13/25 | 18.14 on 01/30/25 | ||
| 6-Month | |||||
| %Chg | -39.24% since 10/28/24 | -2.07% since 10/28/24 | -31.37% since 10/28/24 | ||
| Low | 91.86 on 04/11/25 | 74.07 on 04/07/25 | 10.46 on 04/09/25 | ||
| High | 230.02 on 11/06/24 | 115.59 on 02/13/25 | 20.94 on 10/30/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,723,980 | 6,815,885 | 4,279,250 | ||
| Shares Outstanding, K | 49,116 | 86,496 | 353,365 | ||
| Annual Sales | 4,049,990,000 | 1,199,770,000 | 4,791,000,000 | ||
| Annual Net Income | 22,200,000 | 96,700,000 | -317,000,000 | ||
| Last Quarter Sales | 1,002,550,000 | 311,820,000 | 1,280,000,000 | ||
| Last Quarter Net Income | -214,120,000 | 26,370,000 | -3,000,000 | ||
| 60-Month Beta | 1.45 | 0.49 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.66 on 02/19/25 | 0.69 on 03/18/25 | 0.25 on 02/19/25 | ||
| Latest Earnings Date | 05/07/25 | 06/02/25 | 04/30/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 11.11 | 36.54 | 22.15 | ||